Invasive fungal infections pose an important threat to public health and are an under- recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …
The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
M Nucci, G Barreiros, LF Guimarães… - Mycoses, 2021 - Wiley Online Library
Background The incidence of candidemia in our hospital has been stable over an 18‐year period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an …
H Villanueva-Lozano… - Clinical …, 2021 - clinicalmicrobiologyandinfection …
Since its emergence in December 2019, the rapid spread of coronavirus disease 2019 (COVID-19) has necessitated the expansion and transformation of healthcare facilities …
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a complicated challenge, especially among patients with severe disease. In recent studies …
EE Seagle, BR Jackson, SR Lockhart… - Clinical Infectious …, 2022 - academic.oup.com
Background The COVID-19 pandemic has resulted in unprecedented healthcare challenges, and COVID-19 has been linked to secondary infections. Candidemia, a fungal …
FV Segala, DF Bavaro, F Di Gennaro, F Salvati… - Viruses, 2021 - mdpi.com
Antimicrobial resistance is an urgent threat to public health and global development; in this scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems …
Severe COVID‐19 patients in ICU are at high risk for candidemia due to exposure to multiple risk factors for candidemia. We aimed to compare the incidence of candidemia in ICU …